Friday, October 30, 2026

Automotive

5 articles

U.S. Auto Manufacturing Targets 2028 Software-Defined Vehicle Launch Amid Global Race for Autonomous Technology

U.S. Auto Manufacturing Targets 2028 Software-Defined Vehicle Launch Amid Global Race for Autonomous Technology

American manufacturers plan Software-Defined Vehicle 2.0 architecture rollout for 2028 as the global autonomous driving sector accelerates. The timeline coincides with 2027 defense regulations banning Chinese rare earth materials, forcing domestic supply chain restructuring. The moves position U.S. facilities against European and Asian competitors already deploying Level 3 systems.

LM Salvado•
Rivian Scraps 2027 Profit Goal, Joins Global Race for Autonomous Vehicle Dominance

Rivian Scraps 2027 Profit Goal, Joins Global Race for Autonomous Vehicle Dominance

Rivian Automotive has abandoned its 2027 profitability target to fund autonomous vehicle development, partnering with Uber Technologies in a strategic shift. The decision mirrors choices facing EV manufacturers worldwide as Chinese competitors like BYD and Xpeng advance autonomous capabilities while Western automakers balance short-term returns against AI mobility investments.

LM Salvado•
Renault-Nissan Alliance at Risk as $180B Partnership Faces Strategic Split Over EV Timelines

Renault-Nissan Alliance at Risk as $180B Partnership Faces Strategic Split Over EV Timelines

The Renault-Nissan-Mitsubishi alliance controlling $180 billion in market value faces medium-probability breakup from strategic misalignment. Diverging EV strategies across three continents and unresolved cross-shareholding disputes threaten cost savings of $5.7 billion annually. Institutional investors reduced Nissan holdings 12% amid governance uncertainty.

ViaNews Editorial Team•
Polestar plans 2027 sedan launch as global EV competition intensifies

Polestar plans 2027 sedan launch as global EV competition intensifies

Swedish-Chinese automaker Polestar will launch a redesigned successor to its Polestar 2 sedan in 2027, replacing a model that currently delivers 60% of its European sales. The launch positions the brand against expanding competition from German luxury makers and Chinese EV manufacturers entering Western markets.

ViaNews Editorial Team•
Polestar to Build Compact SUV in Europe by 2028, Targeting €45-65K Premium EV Market

Polestar to Build Compact SUV in Europe by 2028, Targeting €45-65K Premium EV Market

Polestar will manufacture its Polestar 7 compact SUV in Europe starting 2028, marking the Chinese-Swedish brand's first European production facility. The move targets Europe's largest EV segment, where compact SUVs grew 40% in 2024. Local production qualifies vehicles for EU subsidies ranging from €3,000 to €9,000.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,503 source documents archived
Query this data → isubstrate.com